MODEL VERDICT
GP-Act III Acquisition Corp. (GPAT)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| Jun 12, 2026 | NEUTRAL | 0.15 | $10.84 | CURRENT | — |
| Feb 21, 2026 | MODERATE | 0.63 | $10.77 | Scaled in | +0.6% |
| Feb 14, 2026 | MODERATE | 0.63 | $10.76 | Scaled in | +0.6% |
| Feb 11, 2026 | MODERATE | 0.63 | $10.74 | Scaled in | +1.4% |
| Jan 11, 2026 | MODERATE | 0.63 | $10.72 | Scaled in | +1.4% |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Industry Median P/E 1 industry peers | $3.78 | -65.1% | 30% | A | Peer Data |
| Price / Book 2 industry peers | $12.77 | +17.8% | 25% | B | Model Driven |
| Price / Tangible Book 1 bank peers | $20.53 | +89.4% | 20% | B+ | Bank Primary |
| Earnings Yield 1 industry peers | $2.94 | -72.9% | 8% | B | Data |
| Weighted Output Blended model output | $9.96 | -8.1% | 100% | 51 | SLIGHTLY OVERVALUED |
| EPS Growth ↓ | P/E Multiple → | 22× | 24× | 26× (Current) | 28× | 30× |
|---|---|---|---|---|---|
| Bear Case (4%) | $9 | $10 | $11 | $12 | $13 |
| Conservative (7%) | $10 | $10 | $11 | $12 | $13 |
| Base Case (10.0%) | $10 | $11 | $12 | $13 | $14 |
| Bull Case (14%) | $10 | $11 | $12 | $13 | $14 |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
Based on our peer multiples analysis with 8 valuation metrics, the model estimates GPAT's fair value at $9.96 vs the current price of $10.84, implying -8.1% downside potential. Model verdict: Slightly Overvalued. Confidence: 51/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $9.96 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $8.92 (P10) to $11.95 (P90), with a median of $10.44.
GPAT's current P/E of 26.4x compares to the industry median of 9.2x (1 peers in the group). This represents a +187.1% premium to the industry. The historical average P/E is N/Ax over 0 years. Signal: High Premium.
No analyst coverage data is available for GPAT.
The model confidence score is 51/100, based on: data completeness (24), peer quality (14), historical depth (5), earnings stability (5), and model agreement (3). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for GPAT.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.